References
- Schein O. D., Ormerod L. D., Barraquer E., Alfonso E., Egan K. M., Paton B. G., Kenyon K. R. Microbiology of contact lens related keratitis. Cornea 1989; 8: 281–285
- Stern G. A. Pseudomonas keratitis and contact lens wear: The eye/lens is at fault. Cornea 1990; 9: S36–S38, Suppl. 1
- Watt P. J. Pathogenic mechanisms of organisms virulent to the eye. Trans. Ophthalmol. Soc. U.K. 1986; 105: 26–31
- Wilson L. A. Acute bacterial infection of the eye: Bacterial keratitis and endophthalmitis. Trans. Ophthalmol. Soc. U.K. 1986; 105: 43–60
- Stern G. A. Update on the medical management of corneal and external eye diseases, corneal transplantation, and keratorefractive surgery. Ophthalmology 1988; 95: 842–854
- Badenoch P. R., Coster D. J. Antibiotics and corticosteroids: Functions and interactions in ocular disease. “The Cornea: Transactions of the World Congress on the Cornea III”, H. D. Cavanagh. Raven Press, Ltd., New York 1988; 475–483
- Aronson S. B., Moore T. E. Corticosteroid therapy in central stromal keratitis. Am. J. Ophthalmol. 1969; 64: 873–896
- Fauci A. S. Clinical aspects of immunosuppression: Use of cytotoxic agents and corticosteroids. “Immunology II”, J. A. Bellanti. W.B. Saunders Co., Philadelphia 1978; 740–757
- Rootman D. S., Hobden J. A., Jantzen J. A., Gonzalez V. R., O'Callaghan R. J., Hill J. M. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit. Arch. Ophthalmol. 1988; 106: 262–265
- Hobden J. A., Rootman D. S., O'Callaghan R. J., Hill J. M. Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas. Antimicrob. Agents Chemother. 1988; 32: 978–981
- Hobden J. A., Reidy J. J., O'Callaghan R. J., Hill J. M. Ciprofloxacin iontophoresis for aminoglycoside-resistant pseudomonal keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1940–1944
- Hobden J. A., Reidy J. J., O'Callaghan R. J., Insler M. S., Hill J. M. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2241–2243
- Reidy J. J., Hobden J. A., Hill J. M., Forman K., O'Callaghan R. J. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1991; 10: 25–28
- Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: Selection of a control strain and criteria for magnesium and calcium content in the media. J. Infect. Dis. 1974; 130: 454–463
- Lammousin-White M., O'Callaghan R. J. Association between colistin resistance and broad-spectrum recipient deficiency in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 1986; 30: 964–965
- Johnson M. K., Hobden J. A., Hagenah M., O'Callaghan R. J., Hill J. M., Chen S. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr. Eye Res. 1990; 9: 1107–1114
- SAS Institute, Inc. SAS/STAT Guide for Personal Computers. Version 6Edition. SAS Institute, Cary, North Carolina 1987
- Leibowitz H. M., Kupferman A. Topically administered corticosteroids. Effect on antibiotic-treated bacterial keratitis. Arch. Ophthalmol. 1980; 98: 1287–1290
- Gritz D. C., Lee T. Y., Kwitko S., McDonnell P. J. Topical anti-inflammatory agents in an animal model of microbial keratitis. Arch. Ophthalmol. 1990; 108: 1001–1005
- Carmichael T. R., Gelfand Y., Welsh N. H. Topical steroids in the treatment of central and paracentral corneal ulcers. Br. J. Ophthalmol. 1990; 74: 528–531
- Leibowitz H. M., Kupferman A. Use of corticosteroids in the treatment of corneal inflammation. “Corneal Disorders, Clinical Diagnosis and Management”, H. M. Leibowitz. W. B. Saunders Co., Philadelphia 1984; 286–310
- Mandelbaum S., Udell I. J. Corneal perforations associated with infectious agents. “Surgical Intervention in Corneal and External Diseases”, R. L. Abbott. Grune and Stratton, Inc., Orlando 1987; 107–118